Rockwell Medical Inc (NASDAQ: RMTI) is screaming for the top in the market this morning, and for good reason. The company announced a new regulatory approval, setting the stage for a new revenue opportunity. Here’s what’s going on:
RMTI Announces Regulatory Approval
In a press release issued early this morning, Rockwell Medical said Jeil Pharmaceutical, its South Korean partner, has received regulatory approval by the Ministry of Food and Drug Safety, or MFDS, in the Republic of Korea.
Read more about RMTI stock here
This article originally appeared at CNA Finance.